Loading clinical trials...
Loading clinical trials...
Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?
The main objective of the study is to contribute to a better understanding of the physiopathology of schizophrenia, by studying causal relationships between cognitive deficits and the neurobiological basis for these deficits. Processing visual information involves both automatic grouping processes and control processes. Automatic grouping processes allow the building of a global configuration from local contour information. It is necessary in order to recognize objects. Control processes allow tending to and prioritizing information parts. The paradigm the investigators use allows to dissociate these processes, and is used in order to characterize the impairments observed in patients with schizophrenia. It is adapted to fMRI in order to explore the neurobiological basis of the deficits. The investigators will examine whether functional disconnectivity between activated areas subtend the impairments observed in patients.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
Inserm U666 - Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Start Date
September 1, 2006
Completion Date
April 1, 2009
Last Updated
June 28, 2010
52
ESTIMATED participants
fMRI
PROCEDURE
Lead Sponsor
University Hospital, Strasbourg, France
Collaborators
NCT07455929
NCT06740383
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions